



Perhaps one of the greatest benefits in the conquest of tuberculosis was the
introduction of BCG vaccine. Dr Honor Purser, in a paper published in the Ulster
Medical Journal and reprinted in the Fourth Annual Report of the Northern
Ireland Tuberculosis Authority recounted: 'In 1908 Calmette and Guerin began
to grow a particular strain of bovine tubercle bacillus on special culture media.
Koch had used the human strain of tubercle bacillus. The research continued
over many years, using different experimental animals, first to determine the
harmlessness of the vaccine and secondly to test its immunising powers. Finally
in 1923 it was given to newborn infants in Paris with no ill effects and with some
success. These years of experiment were necessary in order to produce a vaccine
that was stable in virulence and potency, one that was incapable of producing a
progressive tuberculous disease and at the same time had the power of conjuring
up the protective mechanisms of the body so that a possible virulent infection
would be successfully resisted'.
It was called BCG vaccine, meaning the Bacillus of Calmette and Guerin. The
vaccine produced today is still grown from the original strain of organism. In
the early years the vaccine was imported from Denmark. It was a fresh liquid
preparation which arrived weekly packed in ice, and had to be collected and put
into a refrigerator for distribution. This was later replaced by a freeze-dried
vaccine made in England which was more easily distributed.
BCG vaccination had two benefits - the preliminary tuberculin tests could detect
those hitherto uninfected and at risk of developing tuberculosis, and it could
protect them from their first infection. This was done by injecting a small amount
of tuberculin into the skin or applying a jelly containing it to a scarified area.
From the local reaction which followed, it was possible to identify those who
were already infected and those who were hitherto uninfected and required
vaccination. It was thought that the protection provided by vaccination would last
at least for five years, though, if need be, the vaccination could be repeated. In
the case of children, they had to be separated from a probable source of their
infection for six weeks before and after vaccination.
BCG vaccination was begun in July 1949, at first by Dr Purser working alone.
Since in the first instance supplies of the vaccine were limited, it had to be
restricted to those most at risk, such as doctors, medical students, nurses, ward
maids, contacts not already infected, and newborn babies - particularly those
whose mothers had tubercle bacillusin theirsputum. In April 1952 Dr H G Calwell
was appointed Medical Director of BCG Services. He was to take charge of the
special department and to co-ordinate BCG vaccination in Northern Ireland.
Dr Calwell realised that it was essential to obtain support for the project from the
Northern Ireland Hospitals Authority and from the county and county borough
health committees in order that the scheme might be adopted in the children's
hospitals, the maternity hospitals, the schools and the welfare services. In this he
was conspicuously successful. He also attempted to introduce the scheme into
factories so that the 18 to 23 age group could be protected. The BCG clinics wereaccompanied by the presence ofthe mobile mass radiography unit. The response
here wasa little disappointing, though somefirms welcomed the scheme. Routine
vaccination of school leavers was begun in 1953.
During this year there were 15,094 tuberculin tests carried out, 9,948 of those
tested were found to be hitherto uninfected and therefore susceptible to infection
and required vaccination. The main task ofthe BCG clinics during this period was
the vaccination of family and other contacts referred by chest physicians, and the
following up of those vaccinated since 1949. This entailed clinical examination,
annual post-vaccination tuberculin tests, and, where necessary, radiography.
New clinics were opened up in the Enniskillen and Derry areas. Dr Leitch was
appointed full time to organise and conduct clinics in various areas in the region
and to vaccinate nurses and infants in the maternity hospitals. The Queen's
University Students' Medical Service began a BCG clinic.
A ward with five cots was opened in the Crawfordsburn Hospital. This was to
remove infants from an infected family environment, where either father or
mother was suffering from active sputum -positive tuberculosis, and contact with
the infection could not otherwise be broken; such contact was especially
dangerous to infants. During 1957 it is recorded that 17 newborn babies were
admitted to the isolation nursery.
In 1954 the volume of work continued to increase: 24,250 vaccinations were
done. Vaccination of newborn infants was begun in the Mater Hospital, and
domiciliary vaccinations in Belfast, especially of newborn infants, began. This was
a great convenience for the parents, and enabled infants to be more effectively
dealt with. In 1955 there were 41,237 vaccinations, a substantial increase on the
previous year. The number of home vaccinations had increased greatly and a
BCG clinic was opened in the Ulster Hospital. In the 10 years before the Authority
gave up its responsibilities 170,000 vaccinations were carried out, mainly on
newborn babies, contacts and children about to leave school.
In 1956 however there began a significant change in the BCG vaccination
pattern - there was an obvious fall in the natural reactor rate. A falling reactor
rate indicates increasingly successful tuberculosis control. The fall in the
natural reactor rate continued in the remaining few years of the Northern Ireland
Tuberculosis Authority's existence. In 1959 - the last year - it was 21 %
compared with 25% in 1957 and 46-3% in 1954. This was a clear indication
that tuberculosis in Northern Ireland had begun to decline. One authority
stated that tuberculosis would cease to be a public health risk when the reactor
rate in adolescents was 1%.
BCG vaccination is still offered as a routine to all adolescent schoolchildren in
Northern Ireland. This position will have been reviewed in the light of the results
of a survey to be completed in 1987. In England serious consideration is being
given to abandoning BCG completely.
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